Tuesday 11 January 2022

Pfizer developing vaccine that targets omicron; Chicago set to resume in-person classes: COVID-19 updates

Pfizer's CEO Albert Bourla said developing a COVID vaccine specifically designed to target the omicron variant is "the most likely scenario." Updates.

     


from USATODAY - News Top Stories https://ift.tt/33pb8B2

No comments:

Post a Comment